Skip to main content

Patient Access

By Jessica Hagen | 05:09 pm | June 26, 2025
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 
By Jessica Hagen | 12:00 pm | June 26, 2025
Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.
HIMSS25
By HIMSS TV | 04:21 pm | June 24, 2025
Joan Webley of Hospitals Without Borders, which provides modular hospitals and clinics to regions in need, says attending HIMSS25 helped her gain insights and connect with people interested in the organization's mission.
By Jessica Hagen | 03:19 pm | June 23, 2025
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
By Jessica Hagen | 12:12 pm | June 19, 2025
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
By Jessica Hagen | 05:08 pm | June 17, 2025
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
By Adam Ang | 10:15 am | June 13, 2025
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.
By Adam Ang | 09:57 am | June 13, 2025
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
By Anthony Vecchione | 05:31 pm | June 10, 2025
The company will use the funds to grow the company, increase manufacturing operations and put in place more products in the research and development pipeline.  
By Jessica Hagen | 04:17 pm | June 10, 2025
The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.